\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ vital\\ signs\\ demonstrated\\ afebrile\\ pt\\ with\\ bp\\ 159\\/77\\,\\ hr\\ 82\\,\\ rr\\ 22\\.\\ \\ initial\\ exam\\ wnl\\,\\ including\\ neurologic\\ exam\\.\\ \\ hd\\#5\\,\\ mild\\ gait\\ disturbance\\ noted\\ with\\ deviation\\ to\\ the\\ left\\,\\ and\\ deficits\\ in\\ high\\ level\\ and\\ dynamic\\ gait\\ activity\\.\ \(0\)\
\-\ labs\\:\\ spep\\,\\ protein\\ c\\,\\ protein\\ s\\,\\ antithrombin\\ iii\\,\\ hypercoag\\ panel\\,\\ ana\\,\\ ena\\,\\ rf\\,\\ b12\\,\\ folate\\,\\ mma\\,\\ coagii\\,\\ esr\\,\\ crp\\,\\ homocysteine\\,\\ cardiolipin\\ panel\\,\\ rpr\\,\\ lipid\\ panel\\ all\\ wnl\\.\\ \ \(0\)\
\-\ an\\ lp\\ was\\ performed\\ and\\ wnl\\.\ \(0\)\
\-\ tte\\ and\\ tee\\ both\\ showed\\ no\\ abnormalities\\ or\\ clots\\.\ \(0\)\
\-\ this\\ pt\\ is\\ being\\ transitioned\\ from\\ effexor\\ to\\ zoloft\\,\\ his\\ htn\\ is\\ being\\ addressed\\ with\\ hctz\\,\\ and\\ he\\ will\\ receive\\ rehabilitative\\ treatment\\ from\\ pm\\&r\\ and\\ physical\\ therapy\\.\\ \\ \\ \ \(0\)\
\-\ his\\ medical\\ conditions\\ will\\ continue\\ to\\ be\\ followed\\ by\\ psychiatry\\,\\ medicine\\,\\ and\\ neurology\\.\ \(0\)\
\-\ \\‚\\Ä\\¢ct\\ on\\ hd\\#1\\ demonstrated\\ no\\ evidence\\ of\\ infarction\\,\\ inflammation\\,\\ or\\ bleeding\\.\ \(0\)\
\-\ \\‚\\Ä\\¢ct\\ on\\ hd\\#3\\ showed\\ a\\ change\\ in\\ density\\ in\\ areas\\ of\\ the\\ left\\ cerebellum\ \(0\)\
\-\ \\‚\\Ä\\¢mri\\/mra\\ of\\ the\\ head\\ and\\ brain\\ on\\ hd\\#4\\ demonstrated\\ subacute\\ l\\ pica\\ territory\\ infarcts\\ and\\ normal\\ intracranial\\ mra\\.\ \(0\)\
\-\ \\‚\\Ä\\¢mri\\/mra\\ of\\ the\\ neck\\ on\\ hd\\#5\\ demonstrated\\ no\\ dissection\\,\\ aneurysm\\ or\\ focal\\ stenosis\\ of\\ the\\ vertebral\\ arteries\\.\ \(0\)\
\-\ cerebellar\\ pica\\ infarction\ \(0\)\
\-\ \\‚\\Ä\\¢\\ cerebellar\\ embolic\\ infarction\ \(0\)\
\-\ \\‚\\Ä\\¢\\ vertebral\\ artery\\ dissection\ \(0\)\
\-\ 47\\ yo\\ man\\ with\\ 6\\ month\\ hx\\ of\\ headaches\\ \\-\\ now\\ reports\\ experiencing\\ \\‚\\Ä\\úworst\\ headache\\ of\\ his\\ life\\‚\\Ä\\ù\\ accompanied\\ by\\ nausea\\,\\ vomiting\\,\\ and\\ dizziness\\.\\ pt\\ notes\\ waking\\ up\\ with\\ a\\ mild\\ headache\\ on\\ the\\ day\\ of\\ admission\\,\\ unrelieved\\ by\\ caffeine\\ consumption\\,\\ that\\ progressively\\ worsened\\.\\ the\\ pain\\ was\\ sharp\\,\\ but\\ throbbing\\ and\\ located\\ behind\\ his\\ left\\ eye\\ and\\ radiating\\ posteriorly\\.\ \(0\)\
\-\ this\\ patient\\ had\\ an\\ atypical\\ presentation\\ for\\ stroke\\,\\ without\\ any\\ of\\ the\\ classic\\ risk\\ factors\\.\\ \\ while\\ it\\ is\\ true\\ that\\ headaches\\ are\\ sometimes\\ seen\\ with\\ stroke\\,\\ this\\ patient\\ had\\ no\\ focal\\ neurologic\\ findings\\ at\\ the\\ time\\ of\\ his\\ presentation\\,\\ which\\ confused\\ the\\ picture\\.\\ \\ his\\ headache\\ presentation\\ was\\ most\\ consistent\\ with\\ migraine\\,\\ if\\ one\\ assumes\\ a\\ primary\\ headache\\.\\ \\ if\\ one\\ looks\\ further\\ for\\ causes\\ of\\ secondary\\ headache\\,\\ the\\ differential\\ includes\\ subarachnoid\\ hemorrhage\\ \\(sah\\)\\,\\ aneurysm\\,\\ acute\\ ischemic\\ cerebrovascular\\ disorder\\,\\ arteritis\\,\\ artery\\ dissection\\,\\ hypertension\\(htn\\)\\,\\ pseudotumor\\ cerebri\\,\\ infection\\,\\ and\\ substance\\ use\\ or\\ withdrawal\\.\\ \\ \ \(0\)\
\-\ \\	in\\ this\\ case\\,\\ the\\ team\\ did\\ a\\ ct\\ for\\ bleeding\\ including\\ sah\\ and\\ mass\\ effect\\,\\ which\\ was\\ negative\\,\\ blood\\ work\\ to\\ rule\\ out\\ arteritis\\ and\\ infection\\,\\ and\\ \\(later\\)\\ an\\ mra\\ to\\ examine\\ the\\ arteries\\,\\ which\\ was\\ also\\ normal\\ everywhere\\ but\\ the\\ l\\ pica\\.\\ physical\\ exam\\ and\\ lumbar\\ puncture\\ ruled\\ out\\ pseudotumor\\ cerebri\\ in\\ this\\ case\\.\\ that\\ leaves\\ htn\\,\\ ischemia\\/infarct\\,\\ and\\ substance\\ or\\ drug\\ use\\ or\\ withdrawal\\.\ \(0\)\
\-\ \\	the\\ patient\\'s\\ systolic\\ blood\\ pressure\\ was\\ elevated\\ on\\ presentation\\,\\ and\\ with\\ further\\ digging\\,\\ continued\\ to\\ remain\\ elevated\\ during\\ his\\ hospital\\ course\\ \\(with\\ diastolic\\ also\\ elevated\\ most\\ of\\ the\\ time\\)\\.\\ it\\ is\\ possible\\ that\\ his\\ blood\\ pressure\\ had\\ been\\ elevated\\ for\\ quite\\ some\\ time\\,\\ leading\\ to\\ an\\ occult\\ risk\\ factor\\.\\ \\ if\\ his\\ headache\\ was\\ a\\ caused\\ by\\ a\\ hypertensive\\ crisis\\,\\ one\\ would\\ expect\\ his\\ blood\\ pressure\\ to\\ be\\ further\\ elevated\\ on\\ presentation\\.\\ \ \(0\)\
\-\ \\	the\\ patient\\ was\\ taking\\ effexor\\ \\(venlafaxine\\)\\,\\ which\\ is\\ a\\ selective\\ serotonin\\/\\ norepinephrine\\ reuptake\\ inhibitor\\(snri\\)\\,\\ and\\ has\\ both\\ htn\\ and\\ headaches\\ as\\ possible\\ side\\ effects\\.\\ \\ stroke\\ is\\ not\\ listed\\ as\\ a\\ known\\ side\\ effect\\.\\ \\ however\\,\\ there\\ is\\ one\\ case\\ study\\ in\\ the\\ literature\\ that\\ describes\\ a\\ patient\\ having\\ a\\ \\"migraine\\-like\\"\\ stroke\\ while\\ having\\ a\\ serotonin\\ syndrome\\.\\ \\ serotonin\\ syndrome\\ is\\ caused\\ by\\ too\\ much\\ serotonin\\ in\\ the\\ brain\\,\\ usually\\ secondary\\ to\\ patients\\ taking\\ ssris\\/\\ snris\\ and\\ then\\ taking\\ a\\ second\\ serotonin\\ promoter\\.\\ \\ it\\ does\\ sometimes\\ occur\\ when\\ patients\\ are\\ taking\\ elevated\\ doses\\ of\\ medication\\.\\ \\ it\\ is\\ unknown\\ how\\ long\\ this\\ patient\\ was\\ taking\\ effexor\\ before\\ his\\ headaches\\ began\\ or\\ if\\ he\\ experienced\\ any\\ of\\ the\\ other\\ symptoms\\ of\\ serotonin\\ syndrome\\,\\ including\\ acute\\ mental\\ status\\ changes\\,\\ involuntary\\ movements\\,\\ altered\\ muscle\\ tone\\,\\ and\\ autonomic\\ instability\\.\\ \\ even\\ if\\ the\\ patient\\ did\\ not\\ have\\ serotonin\\ syndrome\\ on\\ presentation\\,\\ it\\ is\\ worth\\ noting\\ that\\ he\\ received\\ sumatriptan\\ while\\ in\\ the\\ hospital\\,\\ while\\ also\\ receiving\\ his\\ venlafaxine\\.\\ \\ \\ could\\ this\\ combination\\ have\\ precipitated\\ a\\ serotonin\\ syndrome\\?\\ \\ certainly\\,\\ however\\,\\ the\\ patient\\ did\\ not\\ report\\ an\\ increase\\ in\\ symptoms\\ after\\ receiving\\ the\\ drug\\,\\ so\\ the\\ possibility\\ is\\ very\\ slim\\.\ \(0\)\
\-\ \\	cocaine\\ is\\ also\\ associated\\ with\\ stroke\\ in\\ the\\ younger\\ population\\.\\ \\ it\\ is\\ associated\\ with\\ vasoconstriction\\,\\ and\\ has\\ been\\ known\\ to\\ cause\\ slow\\ flow\\ in\\ the\\ vertebrobasilar\\ system\\ \\(which\\ supplies\\ the\\ pica\\)\\,\\ among\\ other\\ cerebral\\ infarcts\\,\\ and\\ htn\\.\\ \\ while\\ this\\ patient\\ does\\ not\\ report\\ any\\ cocaine\\ use\\,\\ it\\ is\\ a\\ possibility\\ to\\ be\\ entertained\\.\ \(0\)\
\-\ \\	the\\ actual\\ cause\\ of\\ this\\ patient\\‚\\Ä\\ôs\\ infarct\\ may\\ never\\ be\\ known\\,\\ in\\ part\\ because\\ we\\ do\\ not\\ know\\ when\\ the\\ actual\\ infarct\\ occurred\\.\\ \\ ct\\ best\\ demonstrates\\ signs\\ of\\ cerebral\\ infarct\\ at\\ least\\ 24\\ hours\\ after\\ the\\ event\\.\\ \\ there\\ are\\ cases\\ of\\ ct\\ being\\ used\\ to\\ identify\\ infarcts\\ earlier\\,\\ but\\ this\\ is\\ generally\\ by\\ identifying\\ secondary\\ signs\\ \\(like\\ a\\ clot\\ in\\ the\\ mca\\)\\ and\\ in\\ the\\ cerebrum\\ rather\\ than\\ the\\ cerebellum\\.\\ \\ \\ the\\ differential\\ for\\ headaches\\ is\\ very\\ broad\\,\\ but\\ stroke\\ must\\ be\\ kept\\ in\\ mind\\ especially\\ when\\ no\\ other\\ obvious\\ cause\\ presents\\ itself\\,\\ as\\ it\\ can\\ often\\ be\\ reversed\\ if\\ found\\ early\\ enough\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ clinch\\,cr\\.\\ evaluation\\ of\\ acute\\ headaches\\ in\\ adults\\.\\ amer\\ fam\\ physician\\.\\ 2001\\ feb15\\;63\\(4\\)\\:685\\-92\\.\ \(0\)\
\-\ molaie\\,\\ m\\.\\ serotonin\\ syndrome\\ presenting\\ with\\ migrainelike\\ stroke\\.\\ headache\\.\\ 1997\\ sep\\;37\\(8\\)\\:519\\-21\\.\ \(0\)\
\-\ nanda\\ a\\,\\ vannemreddy\\ p\\,\\ willis\\ b\\,\\ kelley\\ r\\.\\ stroke\\ in\\ the\\ young\\:\\ relationship\\ of\\ active\\ cocaine\\ use\\ with\\ stroke\\ mechanism\\ and\\ outcome\\.\\ acta\\ neurochir\\ suppl\\.\\ 2006\\;96\\:91\\-6\\.\ \(0\)\
\-\ wardlaw\\ jm\\,\\ mielke\\ o\\.\\ early\\ signs\\ of\\ brain\\ infarction\\ at\\ ct\\:\\ observer\\ reliability\\ and\\ outcome\\ after\\ thrombolytic\\ treatment\\-\\-systematic\\ review\\.\\ radiology\\ 2005\\ may\\;235\\(2\\)\\:444\\-53\\.\\ \\ clinch\\,cr\\.\\ evaluation\\ of\\ acute\\ headaches\\ in\\ adults\\.\\ amer\\ fam\\ physician\\.\\ 2001\\ feb15\\;63\\(4\\)\\:685\\-92\\.\ \(0\)\
\-\ caplan\\ lr\\.\\ posterior\\ circulation\\ cerebrovascular\\ syndromes\\.\\ www\\.uptodate\\.com\\.\\ last\\ updated\\ 21nov2006\\.\\ \ \(0\)\
\-\ oliveira\\-filho\\ j\\,\\ koroshetz\\ wj\\.\\ neuroimaging\\ of\\ acute\\ ischemic\\ stroke\\.\\ www\\.uptodate\\.com\\.\\ last\\ updated\\ may\\ 2006\\.\ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\ \(1\)\
\-\ pt\\ notes\\ waking\\ up\\ with\\ a\\ mild\\ headache\\ on\\ the\\ day\\ of\\ admission\\,\\ unrelieved\\ by\\ caffeine\\ consumption\\,\\ that\\ progressively\\ worsened\\.\\ the\\ pain\\ was\\ sharp\\,\\ but\\ throbbing\\ and\\ located\\ behind\\ his\\ left\\ eye\\ and\\ radiating\\ posteriorly\\.\\ the\\ nausea\\ and\\ vomiting\\ began\\ just\\ after\\ lunch\\,\\ and\\ shortly\\ after\\ the\\ patient\\ took\\ a\\ motrin\\ for\\ his\\ headache\\.\\ he\\ denied\\ any\\ fevers\\,\\ chills\\,\\ night\\ sweats\\,\\ recent\\ ill\\ contacts\\,\\ or\\ diarrhea\\.\\ the\\ patient\\ was\\ given\\ ativan\\,\\ morphine\\,\\ phenergan\\,\\ zofran\\ and\\ benadryl\\ along\\ with\\ a\\ 1l\\ bolus\\ of\\ ns\\.\\ ct\\ was\\ performed\\ and\\ determined\\ to\\ be\\ negative\\ for\\ acute\\ pathology\\.\\ on\\ day\\ 2\\,\\ the\\ headache\\ had\\ resolved\\ in\\ the\\ am\\,\\ but\\ iv\\ phenergan\\ was\\ required\\ for\\ nausea\\,\\ and\\ the\\ dizziness\\ persisted\\.\\ the\\ patient\\ reported\\ a\\ headache\\ in\\ the\\ afternoon\\,\\ unresolved\\ with\\ 2\\ separate\\ doses\\ of\\ imitrex\\ \\(sumatriptan\\)\\,\\ but\\ partially\\ alleviated\\ with\\ tylenol\\.\\ the\\ patient\\ continued\\ to\\ experience\\ pain\\ the\\ following\\ day\\,\\ so\\ a\\ repeat\\ ct\\ was\\ done\\,\\ which\\ showed\\ a\\ \\‚\\Ä\\úprobable\\ left\\ cerebellar\\ infarct\\‚\\Ä\\ù\\.\ \(0\)\
\-\ pmhx\\:\\ hypertriglyceridemia\\,\\ psoriasis\\,\\ anxiety\\,\\ g6pd\\,\\ crohns\ \(0\)\
\-\ meds\\:\\ lopid\\ \\(gemfibrozil\\)\\,\\ effexor\\ \\(venlafaxine\\)\ \(0\)\
\-\ allergies\\:\\ iodine\\,\\ primaquin\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ serotonin\\:\\ 0\\.04777865437297972\ \(0\)\
\-\ stroke\\:\\ 0\\.03278536468585961\ \(0\)\
\-\ hd\\:\\ 0\\.026492943057104403\ \(0\)\
\-\ effexor\\:\\ 0\\.025927995364607347\ \(0\)\
\-\ his\\:\\ 0\\.02535326940224783\ \(0\)\
\-\ headache\\:\\ 0\\.023738852803841016\ \(0\)\
\-\ \\,\\:\\ 0\\.022094718582660957\ \(0\)\
\-\ venlafaxine\\:\\ 0\\.01944599652345551\ \(0\)\
\-\ pica\\:\\ 0\\.01861944639464264\ \(0\)\
\-\ htn\\:\\ 0\\.017296487352180836\ \(0\)\
\-\ headaches\\:\\ 0\\.016812570862866874\ \(0\)\
\-\ taking\\:\\ 0\\.016686957003494277\ \(0\)\
\-\ cocaine\\:\\ 0\\.014858993122691165\ \(0\)\
\-\ presentation\\:\\ 0\\.01298559103451948\ \(0\)\
\-\ \\‚\\Ä\\¢mri\\/mra\\:\\ 0\\.012963997682303673\ \(0\)\
\-\ amer\\:\\ 0\\.012963997682303673\ \(0\)\
\-\ feb15\\:\\ 0\\.012963997682303673\ \(0\)\
\-\ \\:685\\-92\\.\\:\\ 0\\.012963997682303673\ \(0\)\
\-\ phenergan\\:\\ 0\\.012963997682303673\ \(0\)\
\-\ elevated\\:\\ 0\\.01279110159423116\ \(0\)\
\-\ \\#\\:\\ 0\\.012322377275517972\ \(0\)\
\-\ caffeine\\:\\ 0\\.01194466359324493\ \(0\)\
\-\ clinch\\:\\ 0\\.01194466359324493\ \(0\)\
\-\ sumatriptan\\:\\ 0\\.011348391375438806\ \(0\)\
\-\ it\\:\\ 0\\.011299108144311863\ \(0\)\
\-\ infarct\\:\\ 0\\.01115187618564771\ \(0\)\
\-\ panel\\:\\ 0\\.011098519389812288\ \(0\)\
\-\ waking\\:\\ 0\\.010925329504186187\ \(0\)\
\-\ unrelieved\\:\\ 0\\.010925329504186187\ \(0\)\
\-\ syndrome\\:\\ 0\\.010781940779711653\ \(0\)\
\-\ www\\.uptodate\\.com\\:\\ 0\\.010597177222841762\ \(0\)\
\-\ \\‚\\Ä\\¢ct\\:\\ 0\\.010329057286380063\ \(0\)\
\-\ infarction\\:\\ 0\\.010272083661259087\ \(0\)\
\-\ if\\:\\ 0\\.010229750443149862\ \(0\)\
\-\ was\\:\\ 0\\.010173445081611481\ \(0\)\
\-\ infarcts\\:\\ 0\\.010138258938508216\ \(0\)\
\-\ throbbing\\:\\ 0\\.010102365110163507\ \(0\)\
\-\ use\\:\\ 0\\.009933644456009715\ \(0\)\
\-\ withdrawal\\:\\ 0\\.009905995415127444\ \(0\)\
\-\ fam\\:\\ 0\\.009905995415127444\ \(0\)\
\-\ while\\:\\ 0\\.009884739852398211\ \(0\)\
\-\ consumption\\:\\ 0\\.009732785068573939\ \(0\)\
\-\ cerebrovascular\\:\\ 0\\.009732785068573939\ \(0\)\
\-\ wnl\\:\\ 0\\.00967213593777173\ \(0\)\
\-\ but\\:\\ 0\\.00938053169649615\ \(0\)\
\-\ pt\\:\\ 0\\.009344599278331625\ \(0\)\
\-\ acute\\:\\ 0\\.009308291157822774\ \(0\)\
\-\ dissection\\:\\ 0\\.009265583618658615\ \(0\)\
\-\ updated\\:\\ 0\\.009192013333095531\ \(0\)\
\-\ actual\\:\\ 0\\.009083031021104764\ \(0\)\
\-\ sah\\:\\ 0\\.008981570915976895\ \(0\)\
\-\ substance\\:\\ 0\\.008981570915976895\ \(0\)\
\-\ doses\\:\\ 0\\.008981570915976895\ \(0\)\
\-\ signs\\:\\ 0\\.0088452233352531\ \(0\)\
\-\ patient\\:\\ 0\\.008817858112374581\ \(0\)\
\-\ arteritis\\:\\ 0\\.008352976776525512\ \(0\)\
\-\ notes\\:\\ 0\\.008290389108262576\ \(0\)\
\-\ cerebri\\:\\ 0\\.008290389108262576\ \(0\)\
\-\ cerebellar\\:\\ 0\\.008130043475831085\ \(0\)\
\-\ day\\:\\ 0\\.007979293615743911\ \(0\)\
\-\ \\(\\:\\ 0\\.007967224921807285\ \(0\)\
\-\ any\\:\\ 0\\.007914220685506746\ \(0\)\
\-\ \\)\\:\\ 0\\.00786990101595557\ \(0\)\
\-\ that\\:\\ 0\\.007596959632288061\ \(0\)\
\-\ nausea\\:\\ 0\\.007588764741799264\ \(0\)\
\-\ cr\\:\\ 0\\.007539174955665532\ \(0\)\
\-\ outcome\\:\\ 0\\.007502862290091456\ \(0\)\
\-\ \\;\\:\\ 0\\.007446401428134536\ \(0\)\
\-\ pressure\\:\\ 0\\.0074027931834316305\ \(0\)\
\-\ demonstrated\\:\\ 0\\.007374764654285198\ \(0\)\
\-\ by\\:\\ 0\\.007323600237289797\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.007271055019203835\ \(0\)\
\-\ receiving\\:\\ 0\\.007271055019203835\ \(0\)\
\-\ 2006\\:\\ 0\\.00724073253802334\ \(0\)\
\-\ this\\:\\ 0\\.007067185392015684\ \(0\)\
\-\ mra\\:\\ 0\\.007044362842987277\ \(0\)\
\-\ which\\:\\ 0\\.00703740259077595\ \(0\)\
\-\ he\\:\\ 0\\.007012315711861822\ \(0\)\
\-\ 63\\:\\ 0\\.006967619088324674\ \(0\)\
\-\ worsened\\:\\ 0\\.006918594940872333\ \(0\)\
\-\ blood\\:\\ 0\\.006860032566203822\ \(0\)\
\-\ one\\:\\ 0\\.006810974656796012\ \(0\)\
\-\ including\\:\\ 0\\.0068060705316020376\ \(0\)\
\-\ did\\:\\ 0\\.0068060705316020376\ \(0\)\
\-\ sharp\\:\\ 0\\.0068027407087354\ \(0\)\
\-\ be\\:\\ 0\\.006782571370152576\ \(0\)\
\-\ progressively\\:\\ 0\\.006758839292338811\ \(0\)\
\-\ dizziness\\:\\ 0\\.006737370469660645\ \(0\)\
\-\ radiating\\:\\ 0\\.006737370469660645\ \(0\)\
\-\ 2001\\:\\ 0\\.00667478280139771\ \(0\)\
\-\ behind\\:\\ 0\\.0066344901922975414\ \(0\)\
\-\ is\\:\\ 0\\.006615185628055595\ \(0\)\
\-\ being\\:\\ 0\\.006568649948824761\ \(0\)\
\-\ after\\:\\ 0\\.0065000044213573615\ \(0\)\
\-\ 159\\/77\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ hypercoag\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ coagii\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ digging\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ serotonin\\/\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ snri\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ migraine\\-like\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ ssris\\/\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ snris\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ molaie\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ migrainelike\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ \\:519\\-21\\.\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ nanda\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ vannemreddy\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ neurochir\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ 96\\:91\\-6\\.\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ wardlaw\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ mielke\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ 235\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ \\:444\\-53\\.\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ 21nov2006\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ oliveira\\-filho\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ koroshetz\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ zofran\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ 1l\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ lopid\\:\\ 0\\.006481998841151837\ \(0\)\
\-\ protein\\:\\ 0\\.006448090625181153\ \(0\)\
\-\ drug\\:\\ 0\\.006448090625181153\ \(0\)\
\-\ a\\:\\ 0\\.006415585029418551\ \(0\)\
\-\ adults\\:\\ 0\\.006413486952519103\ \(0\)\
\-\ sometimes\\:\\ 0\\.006396485743105757\ \(0\)\
\-\ cause\\:\\ 0\\.006377785205629337\ \(0\)\
\-\ began\\:\\ 0\\.006363061844462292\ \(0\)\
\-\ possibility\\:\\ 0\\.006346630520053284\ \(0\)\
\-\ cerebellum\\:\\ 0\\.006251720930145092\ \(0\)\
\-\ in\\:\\ 0\\.006197018090297867\ \(0\)\
\-\ showed\\:\\ 0\\.006180448385125801\ \(0\)\
\-\ ischemic\\:\\ 0\\.006119938343836728\ \(0\)\
\-\ further\\:\\ 0\\.00599436207750057\ \(0\)\
\-\ antithrombin\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ folate\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ mma\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ zoloft\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ rehabilitative\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ assumes\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ leaves\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ ischemia\\/infarct\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ reuptake\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ promoter\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ slim\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ kelley\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ observer\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ lunch\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ ativan\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ imitrex\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ hypertriglyceridemia\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ gemfibrozil\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ primaquin\\:\\ 0\\.005972331796622465\ \(0\)\
\-\ known\\:\\ 0\\.00596481856867019\ \(0\)\
\-\ posteriorly\\:\\ 0\\.0059358748983161305\ \(0\)\
\-\ physician\\:\\ 0\\.005923568648800666\ \(0\)\
\-\ or\\:\\ 0\\.005891310288021809\ \(0\)\
\-\ gait\\:\\ 0\\.0058518184073750295\ \(0\)\
\-\ \\:\\:\\ 0\\.005817590964657835\ \(0\)\
\-\ having\\:\\ 0\\.005772307787859919\ \(0\)\
\-\ l\\:\\ 0\\.0057287316149093725\ \(0\)\
\-\ so\\:\\ 0\\.0057180363806019026\ \(0\)\
\-\ ena\\:\\ 0\\.005674195687719403\ \(0\)\
\-\ everywhere\\:\\ 0\\.005674195687719403\ \(0\)\
\-\ caplan\\:\\ 0\\.005674195687719403\ \(0\)\
\-\ ns\\:\\ 0\\.005674195687719403\ \(0\)\
\-\ brain\\:\\ 0\\.005672098948461975\ \(0\)\
\-\ report\\:\\ 0\\.005625126231158473\ \(0\)\
\-\ admission\\:\\ 0\\.005537738848113178\ \(0\)\
\-\ homocysteine\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ cardiolipin\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ hctz\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ examine\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ wj\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ benadryl\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ afternoon\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ g6pd\\:\\ 0\\.005462664752093093\ \(0\)\
\-\ bleeding\\:\\ 0\\.005455254338332232\ \(0\)\
\-\ had\\:\\ 0\\.005423087703649142\ \(0\)\
\-\ continued\\:\\ 0\\.005411352921935642\ \(0\)\
\-\ when\\:\\ 0\\.005398524788858836\ \(0\)\
\-\ last\\:\\ 0\\.005368724191239683\ \(0\)\
\-\ time\\:\\ 0\\.005324120354204366\ \(0\)\
\-\ on\\:\\ 0\\.005322728032098736\ \(0\)\
\-\ tee\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ psychiatry\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ norepinephrine\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ autonomic\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ precipitated\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ vertebrobasilar\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ suppl\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ o\\.\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ lr\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ unresolved\\:\\ 0\\.005298588611420881\ \(0\)\
\-\ ct\\:\\ 0\\.005273398470847248\ \(0\)\
\-\ eye\\:\\ 0\\.005271190892811635\ \(0\)\
\-\ caused\\:\\ 0\\.005271190892811635\ \(0\)\
\-\ secondary\\:\\ 0\\.005269919043769428\ \(0\)\
\-\ 4\\:\\ 0\\.005252143908483188\ \(0\)\
\-\ neurologic\\:\\ 0\\.005247785811479429\ \(0\)\
\-\ arteries\\:\\ 0\\.005202064359905854\ \(0\)\
\-\ located\\:\\ 0\\.0051723544962036195\ \(0\)\
\-\ spep\\:\\ 0\\.0051645286431900314\ \(0\)\
\-\ vasoconstriction\\:\\ 0\\.0051645286431900314\ \(0\)\
\-\ supplies\\:\\ 0\\.0051645286431900314\ \(0\)\
\-\ transitioned\\:\\ 0\\.0050511825550817535\ \(0\)\
\-\ cerebrum\\:\\ 0\\.0050511825550817535\ \(0\)\
\-\ vertebral\\:\\ 0\\.004973230030018027\ \(0\)\
\-\ aneurysm\\:\\ 0\\.004966822228004857\ \(0\)\
\-\ mild\\:\\ 0\\.004963794383671625\ \(0\)\
\-\ also\\:\\ 0\\.004954763510794563\ \(0\)\
\-\ b12\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ tte\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ looks\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ crisis\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ worth\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ entertained\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ acta\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ alleviated\\:\\ 0\\.004952997707563722\ \(0\)\
\-\ the\\:\\ 0\\.004879386518951498\ \(0\)\
\-\ motrin\\:\\ 0\\.0048663925342869695\ \(0\)\
\-\ vomiting\\:\\ 0\\.004797880645654236\ \(0\)\
\-\ 22\\.\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ addressed\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ reversed\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ willis\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ reliability\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ systematic\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ bolus\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ crohns\\:\\ 0\\.004788921566891509\ \(0\)\
\-\ hospital\\:\\ 0\\.004731024213188417\ \(0\)\
\-\ involuntary\\:\\ 0\\.004718840552329505\ \(0\)\
\-\ thrombolytic\\:\\ 0\\.004718840552329505\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.004693383702616411\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.004667075519159389\ \(0\)\
\-\ rpr\\:\\ 0\\.00465486159866066\ \(0\)\
\-\ clots\\:\\ 0\\.00465486159866066\ \(0\)\
\-\ morphine\\:\\ 0\\.00465486159866066\ \(0\)\
\-\ and\\:\\ 0\\.004632584706343857\ \(0\)\
\-\ jm\\:\\ 0\\.0045960066665477655\ \(0\)\
\-\ early\\:\\ 0\\.004595822014180056\ \(0\)\
\-\ very\\:\\ 0\\.004561449438907543\ \(0\)\
\-\ risk\\:\\ 0\\.004551774481410421\ \(0\)\
\-\ mind\\:\\ 0\\.004541515510552382\ \(0\)\
\-\ sep\\:\\ 0\\.004541515510552382\ \(0\)\
\-\ not\\:\\ 0\\.004539774528462998\ \(0\)\
\-\ disturbance\\:\\ 0\\.004490785457988447\ \(0\)\
\-\ diastolic\\:\\ 0\\.004490785457988447\ \(0\)\
\-\ inhibitor\\:\\ 0\\.004490785457988447\ \(0\)\
\-\ noting\\:\\ 0\\.004490785457988447\ \(0\)\
\-\ psoriasis\\:\\ 0\\.004490785457988447\ \(0\)\
\-\ effect\\:\\ 0\\.004449350372160654\ \(0\)\
\-\ pm\\:\\ 0\\.00444333066303435\ \(0\)\
\-\ rf\\:\\ 0\\.004398753735228148\ \(0\)\
\-\ lp\\:\\ 0\\.004398753735228148\ \(0\)\
\-\ certainly\\:\\ 0\\.004398753735228148\ \(0\)\
\-\ kept\\:\\ 0\\.004398753735228148\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.004398753735228148\ \(0\)\
\-\ to\\:\\ 0\\.004396289351618976\ \(0\)\
\-\ side\\:\\ 0\\.004353597796711869\ \(0\)\
\-\ cerebral\\:\\ 0\\.004353597796711869\ \(0\)\
\-\ other\\:\\ 0\\.004344790916255401\ \(0\)\
\-\ an\\:\\ 0\\.00434435611869386\ \(0\)\
\-\ selective\\:\\ 0\\.0043169701800000425\ \(0\)\
\-\ for\\:\\ 0\\.004288871462604206\ \(0\)\
\-\ does\\:\\ 0\\.0042876780446823625\ \(0\)\
\-\ ana\\:\\ 0\\.004279254522362138\ \(0\)\
\-\ lipid\\:\\ 0\\.004279254522362138\ \(0\)\
\-\ territory\\:\\ 0\\.00424337940164932\ \(0\)\
\-\ contacts\\:\\ 0\\.00424337940164932\ \(0\)\
\-\ tylenol\\:\\ 0\\.00424337940164932\ \(0\)\
\-\ possible\\:\\ 0\\.004232326792476576\ \(0\)\
\-\ persisted\\:\\ 0\\.004209173507800134\ \(0\)\
\-\ expect\\:\\ 0\\.004176488388262756\ \(0\)\
\-\ know\\:\\ 0\\.004176488388262756\ \(0\)\
\-\ initial\\:\\ 0\\.004164091387175453\ \(0\)\
\-\ out\\:\\ 0\\.004153020407144876\ \(0\)\
\-\ exam\\:\\ 0\\.004140957220476922\ \(0\)\
\-\ may\\:\\ 0\\.004134547872569391\ \(0\)\
\-\ case\\:\\ 0\\.004123906837207215\ \(0\)\
\-\ worst\\:\\ 0\\.004115178381689924\ \(0\)\
\-\ listed\\:\\ 0\\.004115178381689924\ \(0\)\
\-\ took\\:\\ 0\\.004115178381689924\ \(0\)\
\-\ anxiety\\:\\ 0\\.004115178381689924\ \(0\)\
\-\ ill\\:\\ 0\\.004086339622018394\ \(0\)\
\-\ 2\\:\\ 0\\.004059054036420323\ \(0\)\
\-\ dynamic\\:\\ 0\\.004058589380854536\ \(0\)\
\-\ migraine\\:\\ 0\\.004058589380854536\ \(0\)\
\-\ r\\.\\:\\ 0\\.004058589380854536\ \(0\)\
\-\ differential\\:\\ 0\\.0039896468078719554\ \(0\)\
\-\ iodine\\:\\ 0\\.0039570082496186414\ \(0\)\
\-\ identifying\\:\\ 0\\.003933663618504979\ \(0\)\
\-\ will\\:\\ 0\\.003931589732910503\ \(0\)\
\-\ 82\\:\\ 0\\.003889086690698777\ \(0\)\
\-\ experiencing\\:\\ 0\\.0038677723253507973\ \(0\)\
\-\ accompanied\\:\\ 0\\.0038677723253507973\ \(0\)\
\-\ puncture\\:\\ 0\\.0038677723253507973\ \(0\)\
\-\ meds\\:\\ 0\\.0038677723253507973\ \(0\)\
\-\ crp\\:\\ 0\\.0038470584452282267\ \(0\)\
\-\ neurology\\:\\ 0\\.0038269121406781423\ \(0\)\
\-\ embolic\\:\\ 0\\.0038269121406781423\ \(0\)\
\-\ describes\\:\\ 0\\.0038269121406781423\ \(0\)\
\-\ circulation\\:\\ 0\\.0038269121406781423\ \(0\)\
\-\ quite\\:\\ 0\\.0037882035131153323\ \(0\)\
\-\ occult\\:\\ 0\\.0037882035131153323\ \(0\)\
\-\ team\\:\\ 0\\.003769587477832766\ \(0\)\
\-\ negative\\:\\ 0\\.003753117884374815\ \(0\)\
\-\ identify\\:\\ 0\\.003751431145045728\ \(0\)\
\-\ enough\\:\\ 0\\.003751431145045728\ \(0\)\
\-\ artery\\:\\ 0\\.0037419558707473513\ \(0\)\
\-\ among\\:\\ 0\\.003733712357119948\ \(0\)\
\-\ relationship\\:\\ 0\\.003733712357119948\ \(0\)\
\-\ confused\\:\\ 0\\.003716410520788923\ \(0\)\
\-\ hypertensive\\:\\ 0\\.003716410520788923\ \(0\)\
\-\ how\\:\\ 0\\.003716410520788923\ \(0\)\
\-\ pmhx\\:\\ 0\\.003716410520788923\ \(0\)\
\-\ receive\\:\\ 0\\.0036995064632707624\ \(0\)\
\-\ never\\:\\ 0\\.0036995064632707624\ \(0\)\
\-\ picture\\:\\ 0\\.0036829823045560137\ \(0\)\
\-\ m\\.\\:\\ 0\\.0036829823045560137\ \(0\)\
\-\ allergies\\:\\ 0\\.0036829823045560137\ \(0\)\
\-\ 5\\:\\ 0\\.0036767065035943577\ \(0\)\
\-\ effects\\:\\ 0\\.003666821343733385\ \(0\)\
\-\ younger\\:\\ 0\\.003666821343733385\ \(0\)\
\-\ clot\\:\\ 0\\.003666821343733385\ \(0\)\
\-\ infection\\:\\ 0\\.003652965550107069\ \(0\)\
\-\ mca\\:\\ 0\\.0036510079575415\ \(0\)\
\-\ evaluation\\:\\ 0\\.0036503511703335407\ \(0\)\
\-\ probable\\:\\ 0\\.00362036626901167\ \(0\)\
\-\ s\\:\\ 0\\.0036040700986979222\ \(0\)\
\-\ syndromes\\:\\ 0\\.0035909505817957148\ \(0\)\
\-\ focal\\:\\ 0\\.0035889611825564733\ \(0\)\
\-\ shortly\\:\\ 0\\.0035766725774890222\ \(0\)\
\-\ sweats\\:\\ 0\\.0035766725774890222\ \(0\)\
\-\ altered\\:\\ 0\\.003562666551775277\ \(0\)\
\-\ itself\\:\\ 0\\.0035354303225985494\ \(0\)\
\-\ remain\\:\\ 0\\.0035221814214936387\ \(0\)\
\-\ too\\:\\ 0\\.0035221814214936387\ \(0\)\
\-\ tone\\:\\ 0\\.0035221814214936387\ \(0\)\
\-\ 1997\\:\\ 0\\.0035221814214936387\ \(0\)\
\-\ left\\:\\ 0\\.003515092901738657\ \(0\)\
\-\ deviation\\:\\ 0\\.003509167026567609\ \(0\)\
\-\ performed\\:\\ 0\\.003503791663569587\ \(0\)\
\-\ however\\:\\ 0\\.0034990706699956917\ \(0\)\
\-\ ruled\\:\\ 0\\.0034963789804559405\ \(0\)\
\-\ systolic\\:\\ 0\\.0034963789804559405\ \(0\)\
\-\ separate\\:\\ 0\\.003483809544162337\ \(0\)\
\-\ event\\:\\ 0\\.0034714513689297045\ \(0\)\
\-\ true\\:\\ 0\\.0034473412050892694\ \(0\)\
\-\ experience\\:\\ 0\\.0034473412050892694\ \(0\)\
\-\ been\\:\\ 0\\.003418816013917634\ \(0\)\
\-\ movements\\:\\ 0\\.0034125964368168092\ \(0\)\
\-\ slow\\:\\ 0\\.0034013703543677\ \(0\)\
\-\ continue\\:\\ 0\\.003390313091599656\ \(0\)\
\-\ 2005\\:\\ 0\\.003390313091599656\ \(0\)\
\-\ literature\\:\\ 0\\.0033794196461694056\ \(0\)\
\-\ up\\:\\ 0\\.003379186986844446\ \(0\)\
\-\ occurred\\:\\ 0\\.003327249252072138\ \(0\)\
\-\ we\\:\\ 0\\.0033073752282574915\ \(0\)\
\-\ 47\\:\\ 0\\.0032976360909412993\ \(0\)\
\-\ population\\:\\ 0\\.0032785364685859607\ \(0\)\
\-\ determined\\:\\ 0\\.0032785364685859607\ \(0\)\
\-\ experienced\\:\\ 0\\.0032599204333033944\ \(0\)\
\-\ broad\\:\\ 0\\.0032599204333033944\ \(0\)\
\-\ diarrhea\\:\\ 0\\.0032599204333033944\ \(0\)\
\-\ patients\\:\\ 0\\.0032523155873029792\ \(0\)\
\-\ instability\\:\\ 0\\.0032328513354190442\ \(0\)\
\-\ mechanism\\:\\ 0\\.0032328513354190442\ \(0\)\
\-\ am\\:\\ 0\\.0032328513354190442\ \(0\)\
\-\ subacute\\:\\ 0\\.0032240453125905763\ \(0\)\
\-\ p\\:\\ 0\\.0032240453125905763\ \(0\)\
\-\ both\\:\\ 0\\.0032091176333619432\ \(0\)\
\-\ rr\\:\\ 0\\.0032067434762595515\ \(0\)\
\-\ factor\\:\\ 0\\.0032067434762595515\ \(0\)\
\-\ esr\\:\\ 0\\.003181530922231146\ \(0\)\
\-\ obvious\\:\\ 0\\.003173315260026642\ \(0\)\
\-\ medication\\:\\ 0\\.003165190380477683\ \(0\)\
\-\ combination\\:\\ 0\\.003165190380477683\ \(0\)\
\-\ no\\:\\ 0\\.003163397612881625\ \(0\)\
\-\ 37\\:\\ 0\\.0031571542992040133\ \(0\)\
\-\ least\\:\\ 0\\.0031492050961862074\ \(0\)\
\-\ chills\\:\\ 0\\.0031413409130121284\ \(0\)\
\-\ symptoms\\:\\ 0\\.0031318492307325575\ \(0\)\
\-\ conditions\\:\\ 0\\.003125860465072546\ \(0\)\
\-\ hx\\:\\ 0\\.0031106992244822984\ \(0\)\
\-\ earlier\\:\\ 0\\.0031032342454646385\ \(0\)\
\-\ physical\\:\\ 0\\.0030830959846782917\ \(0\)\
\-\ hr\\:\\ 0\\.003059969171918364\ \(0\)\
\-\ denied\\:\\ 0\\.003059969171918364\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.0030529995072459053\ \(0\)\
\-\ night\\:\\ 0\\.0030529995072459053\ \(0\)\
\-\ part\\:\\ 0\\.003046095286400435\ \(0\)\
\-\ resolved\\:\\ 0\\.003046095286400435\ \(0\)\
\-\ vital\\:\\ 0\\.0030059783862162923\ \(0\)\
\-\ leading\\:\\ 0\\.0030059783862162923\ \(0\)\
\-\ c\\:\\ 0\\.002986711935926569\ \(0\)\
\-\ rather\\:\\ 0\\.002986711935926569\ \(0\)\
\-\ fevers\\:\\ 0\\.002986711935926569\ \(0\)\
\-\ medicine\\:\\ 0\\.0029804003596828983\ \(0\)\
\-\ associated\\:\\ 0\\.0029653861204525025\ \(0\)\
\-\ b\\:\\ 0\\.002961784324400333\ \(0\)\
\-\ repeat\\:\\ 0\\.0029556822635071743\ \(0\)\
\-\ iii\\:\\ 0\\.002949630425906795\ \(0\)\
\-\ work\\:\\ 0\\.0029436279916132944\ \(0\)\
\-\ mental\\:\\ 0\\.0029317681519589684\ \(0\)\
\-\ received\\:\\ 0\\.0029200965716969906\ \(0\)\
\-\ much\\:\\ 0\\.0029086073673564895\ \(0\)\
\-\ like\\:\\ 0\\.0029086073673564895\ \(0\)\
\-\ afebrile\\:\\ 0\\.002902929392287438\ \(0\)\
\-\ most\\:\\ 0\\.002901228149600112\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.0028861538939299594\ \(0\)\
\-\ deficits\\:\\ 0\\.00287517915112358\ \(0\)\
\-\ partially\\:\\ 0\\.00287517915112358\ \(0\)\
\-\ must\\:\\ 0\\.0028643658074546862\ \(0\)\
\-\ r\\:\\ 0\\.0028537091844380927\ \(0\)\
\-\ as\\:\\ 0\\.002851273910060576\ \(0\)\
\-\ j\\:\\ 0\\.002838008357621498\ \(0\)\
\-\ generally\\:\\ 0\\.0028277243561694834\ \(0\)\
\-\ factors\\:\\ 0\\.0028226357952543554\ \(0\)\
\-\ disorder\\:\\ 0\\.0028226357952543554\ \(0\)\
\-\ even\\:\\ 0\\.0027977081837281194\ \(0\)\
\-\ life\\:\\ 0\\.002741119182892731\ \(0\)\
\-\ young\\:\\ 0\\.0027365942817351\ \(0\)\
\-\ bp\\:\\ 0\\.002727627169166116\ \(0\)\
\-\ do\\:\\ 0\\.002727627169166116\ \(0\)\
\-\ atypical\\:\\ 0\\.002723184290889673\ \(0\)\
\-\ review\\:\\ 0\\.002723184290889673\ \(0\)\
\-\ have\\:\\ 0\\.0027212324681839583\ \(0\)\
\-\ inflammation\\:\\ 0\\.0026718638777017746\ \(0\)\
\-\ lumbar\\:\\ 0\\.0026718638777017746\ \(0\)\
\-\ before\\:\\ 0\\.002659574553456377\ \(0\)\
\-\ intracranial\\:\\ 0\\.0026555233359483107\ \(0\)\
\-\ radiology\\:\\ 0\\.0026555233359483107\ \(0\)\
\-\ best\\:\\ 0\\.0026435019109471865\ \(0\)\
\-\ increase\\:\\ 0\\.0026355954464058174\ \(0\)\
\-\ rule\\:\\ 0\\.0026238929057397146\ \(0\)\
\-\ just\\:\\ 0\\.0026238929057397146\ \(0\)\
\-\ references\\:\\ 0\\.002612373702251186\ \(0\)\
\-\ done\\:\\ 0\\.002604793283384376\ \(0\)\
\-\ especially\\:\\ 0\\.0025861772481018098\ \(0\)\
\-\ pathology\\:\\ 0\\.002571616492736972\ \(0\)\
\-\ are\\:\\ 0\\.002569574718815298\ \(0\)\
\-\ presenting\\:\\ 0\\.002560882081397889\ \(0\)\
\-\ at\\:\\ 0\\.0025538893077168374\ \(0\)\
\-\ treatment\\:\\ 0\\.0025435543523542456\ \(0\)\
\-\ reports\\:\\ 0\\.0025330002910579673\ \(0\)\
\-\ includes\\:\\ 0\\.0025330002910579673\ \(0\)\
\-\ hypertension\\:\\ 0\\.002477044891397197\ \(0\)\
\-\ system\\:\\ 0\\.0024738823311770573\ \(0\)\
\-\ hours\\:\\ 0\\.002470733315153527\ \(0\)\
\-\ stenosis\\:\\ 0\\.0024613663844348286\ \(0\)\
\-\ unknown\\:\\ 0\\.002452117279870961\ \(0\)\
\-\ \\?\\:\\ 0\\.002452117279870961\ \(0\)\
\-\ change\\:\\ 0\\.0024490599194675316\ \(0\)\
\-\ causes\\:\\ 0\\.0024460152189778026\ \(0\)\
\-\ 24\\:\\ 0\\.0024429830739896687\ \(0\)\
\-\ second\\:\\ 0\\.002413330099440425\ \(0\)\
\-\ used\\:\\ 0\\.002410429527167619\ \(0\)\
\-\ classic\\:\\ 0\\.002407540352064759\ \(0\)\
\-\ active\\:\\ 0\\.002398940322827118\ \(0\)\
\-\ course\\:\\ 0\\.002370979002540913\ \(0\)\
\-\ has\\:\\ 0\\.002359852897785703\ \(0\)\
\-\ activity\\:\\ 0\\.0023573872270452488\ \(0\)\
\-\ occur\\:\\ 0\\.0023573872270452488\ \(0\)\
\-\ 8\\:\\ 0\\.0023493511457715797\ \(0\)\
\-\ could\\:\\ 0\\.002318057311640112\ \(0\)\
\-\ abnormalities\\:\\ 0\\.0023079151630133947\ \(0\)\
\-\ \\‚\\Ä\\¢\\:\\ 0\\.0023044328699939527\ \(0\)\
\-\ pain\\:\\ 0\\.0023020768401413264\ \(0\)\
\-\ iv\\:\\ 0\\.0022929595128390393\ \(0\)\
\-\ reported\\:\\ 0\\.0022904962136586853\ \(0\)\
\-\ later\\:\\ 0\\.0022686901772006793\ \(0\)\
\-\ required\\:\\ 0\\.002261562876314165\ \(0\)\
\-\ muscle\\:\\ 0\\.0022568494363429006\ \(0\)\
\-\ status\\:\\ 0\\.0022428877361629807\ \(0\)\
\-\ would\\:\\ 0\\.0022360050576633013\ \(0\)\
\-\ then\\:\\ 0\\.0022360050576633013\ \(0\)\
\-\ of\\:\\ 0\\.0022272785446674262\ \(0\)\
\-\ \\&\\:\\ 0\\.0022069028618687\ \(0\)\
\-\ because\\:\\ 0\\.0021981752327838587\ \(0\)\
\-\ labs\\:\\ 0\\.0021852750050993662\ \(0\)\
\-\ long\\:\\ 0\\.002166339346200532\ \(0\)\
\-\ given\\:\\ 0\\.002153981170967899\ \(0\)\
\-\ now\\:\\ 0\\.0021478791100747407\ \(0\)\
\-\ areas\\:\\ 0\\.002114225861210343\ \(0\)\
\-\ recent\\:\\ 0\\.0021122934182645566\ \(0\)\
\-\ followed\\:\\ 0\\.0021065263760138026\ \(0\)\
\-\ cases\\:\\ 0\\.0020932432823390678\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0020913651354235556\ \(0\)\
\-\ flow\\:\\ 0\\.002076510203572438\ \(0\)\
\-\ along\\:\\ 0\\.002076510203572438\ \(0\)\
\-\ density\\:\\ 0\\.0020673759976911465\ \(0\)\
\-\ study\\:\\ 0\\.0020673759976911465\ \(0\)\
\-\ often\\:\\ 0\\.0020047599621468033\ \(0\)\
\-\ found\\:\\ 0\\.0019801658929794945\ \(0\)\
\-\ normal\\:\\ 0\\.0019700183155869134\ \(0\)\
\-\ medical\\:\\ 0\\.0019333160294602973\ \(0\)\
\-\ during\\:\\ 0\\.0019228009190616236\ \(0\)\
\-\ some\\:\\ 0\\.0019080354807843817\ \(0\)\
\-\ usually\\:\\ 0\\.0019080354807843817\ \(0\)\
\-\ yo\\:\\ 0\\.0018906996494873248\ \(0\)\
\-\ month\\:\\ 0\\.001885010691765154\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.0018779608379746\ \(0\)\
\-\ 6\\:\\ 0\\.0018765589421874075\ \(0\)\
\-\ there\\:\\ 0\\.0018701699359779246\ \(0\)\
\-\ from\\:\\ 0\\.0018624054605209004\ \(0\)\
\-\ primary\\:\\ 0\\.0018613119580115414\ \(0\)\
\-\ neck\\:\\ 0\\.001845031718395943\ \(0\)\
\-\ level\\:\\ 0\\.0018109478144462735\ \(0\)\
\-\ changes\\:\\ 0\\.001800770570761074\ \(0\)\
\-\ following\\:\\ 0\\.0017832924683096679\ \(0\)\
\-\ head\\:\\ 0\\.0017820597871866883\ \(0\)\
\-\ all\\:\\ 0\\.0017771496245818314\ \(0\)\
\-\ \\.\\:\\ 0\\.0017227716047241576\ \(0\)\
\-\ high\\:\\ 0\\.001719519162556482\ \(0\)\
\-\ therapy\\:\\ 0\\.0016798829384122155\ \(0\)\
\-\ evidence\\:\\ 0\\.0016473842524756454\ \(0\)\
\-\ than\\:\\ 0\\.0016463594521457896\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0015442169394351596\ \(0\)\
\-\ consistent\\:\\ 0\\.0015406604917876494\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0015145216926340022\ \(0\)\
\-\ 1\\:\\ 0\\.0014950929176174314\ \(0\)\
\-\ noted\\:\\ 0\\.001489280285626907\ \(0\)\
\-\ man\\:\\ 0\\.0014859792963897052\ \(0\)\
\-\ without\\:\\ 0\\.0014794214458515884\ \(0\)\
\-\ 3\\:\\ 0\\.0014713055343430438\ \(0\)\
\-\ with\\:\\ 0\\.0014625522011236219\ \(0\)\
\-\ posterior\\:\\ 0\\.0014482636387518003\ \(0\)\
\-\ can\\:\\ 0\\.001425163494462551\ \(0\)\
\-\ \\'s\\:\\ 0\\.0013853283958581214\ \(0\)\
\-\ demonstrates\\:\\ 0\\.001372515589450872\ \(0\)\
\-\ \\-\\:\\ 0\\.0013468591608149733\ \(0\)\
\-\ findings\\:\\ 0\\.0013373800998455585\ \(0\)\
\-\ presents\\:\\ 0\\.001283561981991122\ \(0\)\
\-\ seen\\:\\ 0\\.0012416379522556546\ \(0\)\
\-\ mass\\:\\ 0\\.0008738683874614445\ \(0\)\
